- Previous Close
0.0000 - Open
0.0250 - Bid 0.0171 x --
- Ask 0.0340 x --
- Day's Range
0.0250 - 0.0250 - 52 Week Range
0.0150 - 0.2060 - Volume
10,000 - Avg. Volume
3,294 - Market Cap (intraday)
1.732M - Beta (5Y Monthly) -0.68
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0400 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Allied Corp., a cannabis company, develops, manufactures, and markets hemp derived cannabis products in the United States. The company operates in two segments, Allied Colombia and Allied Corp. It offers hemp-based CBD natural health products, as well as cannabis related products, including beauty and skincare products, and foods and beverages. The company also develops ALID 10 and ALID 11 for the treatment of post-traumatic stress disorder and related mental health conditions through the targeted function of the 5-HT2 receptor and physiological pathways. Allied Corp. is headquartered in Kelowna, Canada
allied.health--
Full Time Employees
August 31
Fiscal Year Ends
Sector
Recent News: ALID
View MorePerformance Overview: ALID
Trailing total returns as of 3/28/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ALID
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ALID
View MoreValuation Measures
Market Cap
1.73M
Enterprise Value
8.25M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
15.50
Price/Book (mrq)
--
Enterprise Value/Revenue
78.68
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-84.07%
Return on Equity (ttm)
--
Revenue (ttm)
104.81k
Net Income Avi to Common (ttm)
-3.92M
Diluted EPS (ttm)
-0.0400
Balance Sheet and Cash Flow
Total Cash (mrq)
195.35k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-2.1M